Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/11466696

Cancer 2001 Jul 15 92 2 406-13

Download in:

View as

Triples

General Info

PMID
11466696